Factors Associated with Mortality Risk in Patients with Cardiogenic Shock Post-ST-Elevation Myocardial Infarction:
Călin Florin Pop1,2, Camelia Alexandra Coadă3, Mihai Lupu3
1Department of Cardiology, "Constantin Opriş" Emergency County Hospital, 430031 Baia Mare, Romania.
Insights
ST elevation myocardial infarction (STEMI) with cardiogenic shock (CS) has high mortality. Reduced left ventricular ejection fraction (LVEF) and elevated CK-MB levels independently predict in-hospital death in STEMI patients with CS.
Area of Science:
- Cardiology
- Internal Medicine
- Critical Care Medicine
Background:
- ST elevation myocardial infarction (STEMI) is a critical condition.
- Cardiogenic shock (CS) significantly increases STEMI mortality.
- Identifying mortality predictors is crucial for patient management.
Purpose of the Study:
- To identify predictors of in-hospital mortality in STEMI patients.
- To compare outcomes in STEMI patients with and without CS.
- To determine independent predictors of mortality in STEMI with CS.
Main Methods:
- Observational, retrospective case-control study.
- Included 101 STEMI patients (50 with CS, 51 without CS).
- Analyzed demographics, clinical data, lab results, and mortality.
Main Results:
- STEMI patients with CS had significantly higher mortality (52%) vs. without CS (11.76%).
- Univariate analysis identified WBC, CK-MB, CK, creatinine, uric acid, and LVEF as mortality predictors.
- Logistic regression showed reduced LVEF and elevated CK-MB as independent predictors of mortality in STEMI with CS.
Conclusions:
- Reduced systolic function (LVEF) and elevated CK-MB are key predictors of mortality in STEMI with CS.
- Early identification of these factors can guide targeted management strategies.
- Improved outcomes for high-risk STEMI patients with CS are possible through focused interventions.
Abstract:
Background and Objectives: ST elevation myocardial infarction (STEMI), particularly when complicated by cardiogenic shock (CS), is a critical condition associated with high mortality rates. Identifying predictors of in-hospital mortality can enhance patient management and outcomes. Materials and Methods: This observational, retrospective case-control study included STEMI patients, both complicated and uncomplicated by CS. Additionally, demographics, clinical characteristics, laboratory data and in-hospital mortality rates were analysed for STEMI patients with CS and those without CS. Results: This study included a total of 101 patients with STEMI, of whom 51 (50.5%) had STEMI without CS and 50 (49.5%) had STEMI with CS. No significant differences were observed in demographic characteristics or STEMI risk factors between the two groups. Emergency coronarography was performed in 90.1% of the patients, with successful thrombolysis achieved in 24.5%. Patients with CS exhibited a significantly higher mortality (52%) than those without CS (11.76%). Univariate analysis identified white blood cell counts, CK-MB, CK levels, elevated creatinine and uric acid levels and a reduced left ventricular ejection fraction (LVEF) as predictors of mortality. Logistic regression analysis revealed that LVEF and CK-MB were independent predictors of in-hospital mortality in patients with STEMI and CS. Each 1% increase in LVEF was associated with a reduced mortality risk (HR = 0.89; 95% CI 0.81-0.98; p = 0.018), while elevated CK-MB levels were linked to an increased mortality risk (HR = 1; 95% CI 1-1.01; p = 0.014). Conclusions: Reduced systolic function and elevated CK-MB levels are key predictors of in-hospital mortality and outcomes in STEMI patients with CS. These findings underscore the importance of early identification and support the development of targeted management strategies aimed at improving outcomes in this high-risk population.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
